Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4+ T Cells within Colorectal Tumors despite the Presence of Elevated CD39+ T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4+ T Cells within Colorectal Tumors despite the Presence of Elevated CD39+ T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-03-07
DOI
10.3389/fonc.2016.00050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer
- (2015) Changhua Zhuo et al. IMMUNOLOGIC RESEARCH
- Polyfunctional, Pathogenic CD161+Th17 Lineage Cells Are Resistant to Regulatory T Cell–Mediated Suppression in the Context of Autoimmunity
- (2015) Sharee A. Basdeo et al. JOURNAL OF IMMUNOLOGY
- Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation
- (2015) Nicola Gagliani et al. NATURE
- Releasing the Brakes on Cancer Immunotherapy
- (2015) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1+ CD8+ T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients
- (2014) X Wu et al. BRITISH JOURNAL OF CANCER
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
- (2013) Theresa L. Whiteside CANCER IMMUNOLOGY IMMUNOTHERAPY
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
- (2013) Raoul A. Droeser et al. EUROPEAN JOURNAL OF CANCER
- Characteristics and significance of colorectal cancer associated lymphoid reaction
- (2013) Juha P. Väyrynen et al. INTERNATIONAL JOURNAL OF CANCER
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells
- (2013) Daniel S Straus Molecular Cancer
- Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
- (2013) M Scurr et al. Mucosal Immunology
- An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
- (2013) Alicia S Chung et al. NATURE MEDICINE
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
- (2012) Sergei I. Grivennikov et al. NATURE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of ROR t Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
- (2012) N. R. Blatner et al. Science Translational Medicine
- IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
- (2011) Jiankun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
- (2011) Marie Tosolini et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Suppression of tumour-specific CD4+T cells by regulatory T cells is associated with progression of human colorectal cancer
- (2011) Gareth Betts et al. GUT
- Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
- (2011) Pawel Muranski et al. IMMUNITY
- Human TH17 Cells Are Long-Lived Effector Memory Cells
- (2011) I. Kryczek et al. Science Translational Medicine
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
- (2009) Natalia Martin-Orozco et al. IMMUNITY
- High frequency of tumor-infiltrating FOXP3+regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients
- (2009) Daniel M. Frey et al. INTERNATIONAL JOURNAL OF CANCER
- The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
- (2009) Kellie A. Charles et al. JOURNAL OF CLINICAL INVESTIGATION
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells
- (2009) X. Su et al. JOURNAL OF IMMUNOLOGY
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started